Study Comparing Two Strategies of Exercise in Breast and Colon Cancer Survivors and Their Impact on Fatigue
NCT ID: NCT02647398
Last Updated: 2018-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2016-01-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Exercise in Cancer-Related Fatigue in Women After Breast Cancer Treatment
NCT02828189
Effects of a Multimodal Physical Exercise and Functional Rehabilitation Program on Fatigue, Pain, Functional Capacity and Quality of Life in Cancer Patients With Tumor Asthenia.
NCT04761289
Fatigue Before and After Exercise in Patients With Advanced Cancer Stage
NCT01581216
Effects of Exercise Oncology Intervention in Fitness Capacity and Body Composition in Breast Cancer Survivals
NCT05882578
Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment
NCT01495650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The control arm consist of supervised strength training in two sessions per week with non-supervised international recommendations for aerobic exercise. The experimental arm will consist of supervised strength + resistance training in two sessions per week.
After evaluating the weekly physical activity through accelerometer, body composition through DEXA and the cardiorespiratory fitness through CPET, participants will initiate the training according to a randomized assignment.
Secondary objectives include:
1. cardiorespiratory fitness,
2. quality of life;
3. adherence to the training program;
4. adherence to international recommendations,
5. body composition,
6. employment status
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A: Supervised combined training
INTERVENTION: Two supervised 75 min-vigorous aerobic training \& strength training
Vigorous aerobic training
Supervised vigorous aerobic training
B: Supervised strength training
ACTIVE COMPARATOR: Two supervised 45-minute sessions of strength training \& Participants will be advised to comply with international recommendations of physical activity (150 min pf MVPA)
Vigorous aerobic training
Supervised vigorous aerobic training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vigorous aerobic training
Supervised vigorous aerobic training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* history of breast or colon cancer
* no evidence of disease
* end of treatment in the last five years
* able to understand the questionnaire PERFORM
* able to manage the accelerometer
Exclusion Criteria
* treatment with beta-blockers
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Europea de Madrid
OTHER
Puerta de Hierro University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Ruiz-Casado
MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Itziar Pagola, PhD
Role: STUDY_DIRECTOR
Universidad Europea de Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Puerta de Hierro-Majadahonda
Majadahonda, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PH-UEM-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.